# GC012F Injection in the Treatment of Refractory Generalized Myasthenia Gravis(24103)

> **NCT07058298** · EARLY_PHASE1 · RECRUITING · sponsor: **Daishi Tian** · enrollment: 6 (estimated)

## Conditions studied

- Generalized Myasthenia Gravis (gMG)

## Interventions

- **DRUG:** GC012F injection

## Key facts

- **NCT ID:** NCT07058298
- **Lead sponsor:** Daishi Tian
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-07-15
- **Primary completion:** 2027-02-13
- **Final completion:** 2027-09-10
- **Target enrollment:** 6 (ESTIMATED)
- **Last updated:** 2025-09-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07058298

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07058298, "GC012F Injection in the Treatment of Refractory Generalized Myasthenia Gravis(24103)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT07058298. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*